Clinical Trial

A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

Name: A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC. — clinical trial record (NCT06306560)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a single arm, multi-center, phase II trial to evaluate the efficacy, and safety of adebrelimab combined with famitinib and chemotherapy for the treatment of first-line extensive stage small cell lung cancer.

Trial Details

NCT Number	NCT06306560
Lead Sponsor	Harbin Medical University
Conditions	Extensive-stage Small-cell Lung Cancer
Enrollment	40 participants
Start Date	2024-03-15
Primary Completion	2027-03-15 (estimated)
Study Completion	2027-04-15 (estimated)
Updated on ClinicalTrials.gov	2024-03-12